{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T22:31:38Z","timestamp":1789943498622,"version":"4.0.1"},"reference-count":88,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2019,7,10]],"date-time":"2019-07-10T00:00:00Z","timestamp":1562716800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,7,10]],"date-time":"2019-07-10T00:00:00Z","timestamp":1562716800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81800278"],"award-info":[{"award-number":["81800278"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"publisher","award":["13171570"],"award-info":[{"award-number":["13171570"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"crossref","award":["13181097"],"award-info":[{"award-number":["13181097"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Am J Cardiovasc Drugs"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1007\/s40256-019-00357-1","type":"journal-article","created":{"date-parts":[[2019,7,10]],"date-time":"2019-07-10T06:48:41Z","timestamp":1562741321000},"page":"541-552","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Role of Vitamin D in Patients with Heart Failure with Reduced Ejection Fraction"],"prefix":"10.1007","volume":"19","author":[{"given":"Meifang","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaizu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liming","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,10]]},"reference":[{"key":"357_CR1","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1007\/s11897-014-0220-x","volume":"11","author":"SM Dunlay","year":"2014","unstructured":"Dunlay SM, Roger VL. Understanding the epidemic of heart failure: past, present, and future. Curr Heart Fail Rep. 2014;11:404\u201315.","journal-title":"Curr Heart Fail Rep"},{"key":"357_CR2","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1007\/s10557-016-6699-5","volume":"30","author":"LM Lin","year":"2016","unstructured":"Lin LM, Wu Y, Wu MF, Lin JX. Focus on the novel cardiovascular drug LZC696: from evidence to clinical consideration. Cardiovasc Drugs Ther. 2016;30:623\u201333.","journal-title":"Cardiovasc Drugs Ther"},{"key":"357_CR3","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1161\/CIRCULATIONAHA.108.812172","volume":"119","author":"PS Jhund","year":"2009","unstructured":"Jhund PS, Macintyre K, Simpson CR, et al. Long-term trends in first hospitalization for heart failure and subsequent survival between 1986 and 2003: a population study of 5.1 million people. Circulation. 2009;119:515\u201323.","journal-title":"Circulation"},{"key":"357_CR4","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1359\/jbmr.1998.13.3.325","volume":"13","author":"MR Haussler","year":"1998","unstructured":"Haussler MR, Whitfield GK, Haussler CA, et al. The nuclear vitamin D receptor: biological and molecular regulatory properties revealed. J Bone Miner Res. 1998;13:325\u201349.","journal-title":"J Bone Miner Res"},{"key":"357_CR5","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.atherosclerosis.2016.06.005","volume":"251","author":"LM Lin","year":"2016","unstructured":"Lin LM, Peng F, Liu YP, et al. Coadministration of VDR and RXR agonists synergistically alleviates atherosclerosis through inhibition of oxidative stress: an in vivo and in vitro study. Atherosclerosis. 2016;251:273\u201381.","journal-title":"Atherosclerosis"},{"key":"357_CR6","first-page":"1714896","volume":"2018","author":"M Zhang","year":"2018","unstructured":"Zhang M, Lin L. VDR agonist prevents diabetic endothelial dysfunction through inhibition of prolyl isomerase-1-mediated mitochondrial oxidative stress and inflammation. Oxid Med Cell Longev. 2018;2018:1714896.","journal-title":"Oxid Med Cell Longev"},{"key":"357_CR7","first-page":"543","volume":"25","author":"MR Haussler","year":"2011","unstructured":"Haussler MR, Jurutka PW, Mizwicki M, Norman AW. Vitamin D receptor (VDR)-mediated actions of 1alpha,25(OH)(2)vitamin D(3): genomic and non-genomic mechanisms. Best practice and research. Clin Endocrinol Metab. 2011;25:543\u201359.","journal-title":"Clin Endocrinol Metab"},{"key":"357_CR8","doi-asserted-by":"publisher","first-page":"29","DOI":"10.2174\/138945011793591554","volume":"12","author":"LM Meems","year":"2011","unstructured":"Meems LM, van der Harst P, van Gilst WH, de Boer RA. Vitamin D biology in heart failure: molecular mechanisms and systematic review. Curr Drug Targets. 2011;12:29\u201341.","journal-title":"Curr Drug Targets"},{"key":"357_CR9","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s11897-011-0048-6","volume":"8","author":"MD Witham","year":"2011","unstructured":"Witham MD. Vitamin D in chronic heart failure. Curr Heart Fail Rep. 2011;8:123\u201330.","journal-title":"Curr Heart Fail Rep"},{"key":"357_CR10","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1152\/japplphysiol.01506.2012","volume":"114","author":"S Bae","year":"2013","unstructured":"Bae S, Singh SS, Yu H, et al. Vitamin D signaling pathway plays an important role in the development of heart failure after myocardial infarction. J Appl Physiol (Bethesda, Md.: 1985). 2013;114:979\u201387.","journal-title":"J Appl Physiol (Bethesda, Md.: 1985)"},{"key":"357_CR11","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1093\/eurjhf\/hfr032","volume":"13","author":"LC Liu","year":"2011","unstructured":"Liu LC, Voors AA, van Veldhuisen DJ, et al. Vitamin D status and outcomes in heart failure patients. Eur J Heart Fail. 2011;13:619\u201325.","journal-title":"Eur J Heart Fail"},{"key":"357_CR12","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1093\/ajcn\/83.4.754","volume":"83","author":"SS Schleithoff","year":"2006","unstructured":"Schleithoff SS, Zittermann A, Tenderich G, et al. Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: a double-blind, randomized, placebo-controlled trial. Am J Clin Nutr. 2006;83:754\u20139.","journal-title":"Am J Clin Nutr"},{"key":"357_CR13","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1161\/CIRCHEARTFAILURE.109.907899","volume":"3","author":"MD Witham","year":"2010","unstructured":"Witham MD, Crighton LJ, Gillespie ND, et al. The effects of vitamin D supplementation on physical function and quality of life in older patients with heart failure: a randomized controlled trial. Circ Heart Fail. 2010;3:195\u2013201.","journal-title":"Circ Heart Fail"},{"key":"357_CR14","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1056\/NEJMra070553","volume":"357","author":"MF Holick","year":"2007","unstructured":"Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357:266\u201381.","journal-title":"N Engl J Med"},{"key":"357_CR15","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1210\/jc.2011-0385","volume":"96","author":"MF Holick","year":"2011","unstructured":"Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96:1911\u201330.","journal-title":"J Clin Endocrinol Metab"},{"key":"357_CR16","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1210\/jc.2010-2704","volume":"96","author":"AC Ross","year":"2011","unstructured":"Ross AC, Manson JE, Abrams SA, et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab. 2011;96:53\u20138.","journal-title":"J Clin Endocrinol Metab"},{"key":"357_CR17","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s11154-017-9424-1","volume":"18","author":"MF Holick","year":"2017","unstructured":"Holick MF. The vitamin D deficiency pandemic: approaches for diagnosis, treatment and prevention. Rev Endocr Metab Disord. 2017;18:153\u201365.","journal-title":"Rev Endocr Metab Disord"},{"key":"357_CR18","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1007\/s00198-010-1285-3","volume":"21","author":"B Dawsonhughes","year":"2010","unstructured":"Dawsonhughes B, Mithal A, Bonjour JP, et al. IOF position statement: vitamin D recommendations for older adults. Osteoporos Int. 2010;21:1151\u20134.","journal-title":"Osteoporos Int"},{"key":"357_CR19","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1097\/JCN.0000000000000322","volume":"32","author":"NA McKeag","year":"2017","unstructured":"McKeag NA, McKinley MC, Harbinson MT, et al. Dietary micronutrient intake and micronutrient status in patients with chronic stable heart failure: an observational study. J Cardiovasc Nurs. 2017;32:148\u201355.","journal-title":"J Cardiovasc Nurs"},{"key":"357_CR20","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1097\/MAJ.0b013e318167b0bd","volume":"335","author":"S Alsafwah","year":"2008","unstructured":"Alsafwah S, Laguardia SP, Nelson MD, et al. Hypovitaminosis D in African Americans residing in Memphis, Tennessee with and without heart failure. Am J Med Sci. 2008;335:292.","journal-title":"Am J Med Sci"},{"issue":"357\u2013364","key":"357_CR21","first-page":"e352","volume":"166","author":"NF Schroten","year":"2013","unstructured":"Schroten NF, Ruifrok WP, Kleijn L, et al. Short-term vitamin D3 supplementation lowers plasma renin activity in patients with stable chronic heart failure: an open-label, blinded end point, randomized prospective trial (VitD-CHF trial). Am Heart J. 2013;166(357\u2013364):e352.","journal-title":"Am Heart J"},{"issue":"102","key":"357_CR22","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1016\/j.amjcard.2008.06.067","volume":"2008","author":"D Kim","year":"2008","unstructured":"Kim D, Sabour S, Un Adams S, Whellan D. Prevalence of hypovitaminosis D in cardiovascular diseases (from the National Health and Nutrition Examination Survey 2001 to 2004). Am J Cardiol. 2008;2008(102):1540\u20134.","journal-title":"Am J Cardiol"},{"key":"357_CR23","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1093\/eurjhf\/hfr175","volume":"14","author":"I Gotsman","year":"2012","unstructured":"Gotsman I, Shauer A, Zwas DR, et al. Vitamin D deficiency is a predictor of reduced survival in patients with heart failure; vitamin D supplementation improves outcome. Eur J Heart Fail. 2012;14:357\u201366.","journal-title":"Eur J Heart Fail"},{"key":"357_CR24","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.numecd.2010.01.002","volume":"20","author":"P Ameri","year":"2010","unstructured":"Ameri P, Ronco D, Casu M, et al. High prevalence of vitamin D deficiency and its association with left ventricular dilation: an echocardiography study in elderly patients with chronic heart failure. Nutr Metab Cardiovasc Dis NMCD. 2010;20:633\u201340.","journal-title":"Nutr Metab Cardiovasc Dis NMCD"},{"key":"357_CR25","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.jsbmb.2004.03.004","volume":"89\u201390","author":"YC Li","year":"2004","unstructured":"Li YC, Qiao G, Uskokovic M, et al. Vitamin D: a negative endocrine regulator of the renin\u2013angiotensin system and blood pressure. J Steroid Biochem Mol Biol. 2004;89\u201390:387\u201392.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"357_CR26","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1210\/er.2008-0004","volume":"29","author":"R Bouillon","year":"2008","unstructured":"Bouillon R, Carmeliet G, Verlinden L, et al. Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr Rev. 2008;29:726\u201376.","journal-title":"Endocr Rev"},{"key":"357_CR27","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1172\/JCI0215219","volume":"110","author":"YC Li","year":"2002","unstructured":"Li YC, Kong J, Wei M, et al. 1,25-Dihydroxyvitamin D3 is a negative endocrine regulator of the renin\u2013angiotensin system. J Clin Investig. 2002;110:229\u201338.","journal-title":"J Clin Investig"},{"key":"357_CR28","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1161\/HYPERTENSIONAHA.109.148619","volume":"55","author":"JP Forman","year":"2010","unstructured":"Forman JP, Williams JS, Fisher ND. Plasma 25-hydroxyvitamin D and regulation of the renin-angiotensin system in humans. Hypertension (Dallas, Tex.: 1979). 2010;55:1283\u20138.","journal-title":"Hypertension (Dallas, Tex.: 1979)"},{"key":"357_CR29","first-page":"Iii21","volume":"81","author":"JP Morgan","year":"1990","unstructured":"Morgan JP, Erny RE, Allen PD, et al. Abnormal intracellular calcium handling, a major cause of systolic and diastolic dysfunction in ventricular myocardium from patients with heart failure. Circulation. 1990;81:Iii21\u201332.","journal-title":"Circulation"},{"key":"357_CR30","doi-asserted-by":"publisher","first-page":"e61","DOI":"10.1161\/01.RES.0000125626.33738.E2","volume":"94","author":"XH Wehrens","year":"2004","unstructured":"Wehrens XH, Lehnart SE, Reiken SR, Marks AR. Ca2+\/calmodulin-dependent protein kinase II phosphorylation regulates the cardiac ryanodine receptor. Circ Res. 2004;94:e61.","journal-title":"Circ Res"},{"key":"357_CR31","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.jsbmb.2006.12.098","volume":"103","author":"R Simpson","year":"2007","unstructured":"Simpson R, Hershey S, Nibbelink K. Characterization of heart size and blood pressure in the vitamin D receptor knockout mouse. J Steroid Biochem Mol Biol. 2007;103:521\u20134.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"357_CR32","doi-asserted-by":"publisher","first-page":"e108382","DOI":"10.1371\/journal.pone.0108382","volume":"9","author":"S Choudhury","year":"2014","unstructured":"Choudhury S, Bae S, Ke Q, et al. Abnormal calcium handling and exaggerated cardiac dysfunction in mice with defective vitamin d signaling. PLoS One. 2014;9:e108382.","journal-title":"PLoS One"},{"key":"357_CR33","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1007\/s10741-018-9716-x","volume":"23","author":"M Bartekova","year":"2018","unstructured":"Bartekova M, Radosinska J, Jelemensky M, Dhalla NS. Role of cytokines and inflammation in heart function during health and disease. Heart Fail Rev. 2018;23:733\u201358.","journal-title":"Heart Fail Rev"},{"key":"357_CR34","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.yexmp.2012.04.006","volume":"93","author":"GK Gupta","year":"2012","unstructured":"Gupta GK, Agrawal T, Delcore MG, et al. Vitamin D deficiency induces cardiac hypertrophy and inflammation in epicardial adipose tissue in hypercholesterolemic swine. Exp Mol Pathol. 2012;93:82\u201390.","journal-title":"Exp Mol Pathol"},{"key":"357_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2015\/547697","volume":"2015","author":"Y Ma","year":"2015","unstructured":"Ma Y, Zhou Y, Yue C, et al. Vitamin D deficiency contributes to the reduction and impaired function of na\u00efve CD45RA+ regulatory T cell in chronic heart failure. J Immunol Res. 2015;2015:1\u201318.","journal-title":"J Immunol Res"},{"key":"357_CR36","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1172\/JCI113004","volume":"79","author":"WF Rigby","year":"1987","unstructured":"Rigby WF, Denome S, Fanger MW. Regulation of lymphokine production and human T lymphocyte activation by 1,25-dihydroxyvitamin D3. Specific inhibition at the level of messenger RNA. J Clin Investig. 1987;79:1659\u201364.","journal-title":"J Clin Investig"},{"key":"357_CR37","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1093\/ajcn\/83.4.754","volume":"83","author":"SS Schleithoff","year":"2006","unstructured":"Schleithoff SS, Zittermann A, Tenderich G, et al. Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: a double-blind, randomized, placebo-controlled trial. Am J Clin Nutr. 2006;83:754\u20139.","journal-title":"Am J Clin Nutr"},{"key":"357_CR38","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1038\/s41598-018-19708-0","volume":"8","author":"AJ Rodriguez","year":"2018","unstructured":"Rodriguez AJ, Mousa A, Ebeling PR, et al. Effects of vitamin D supplementation on inflammatory markers in heart failure: a systematic review and meta-analysis of randomized controlled trials. Sci Rep. 2018;8:1169.","journal-title":"Sci Rep"},{"key":"357_CR39","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1016\/j.amjmed.2011.07.009","volume":"124","author":"W Saliba","year":"2011","unstructured":"Saliba W, Barnett O, Rennert HS, et al. The relationship between serum 25(OH)D and parathyroid hormone levels. Am J Med. 2011;124:1165\u201370.","journal-title":"Am J Med"},{"key":"357_CR40","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/S0008-6363(97)00194-6","volume":"37","author":"KD Schluter","year":"1998","unstructured":"Schluter KD, Piper HM. Cardiovascular actions of parathyroid hormone and parathyroid hormone-related peptide. Cardiovasc Res. 1998;37:34\u201341.","journal-title":"Cardiovasc Res"},{"key":"357_CR41","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1161\/CIRCHEARTFAILURE.114.001272","volume":"7","author":"SG Wannamethee","year":"2014","unstructured":"Wannamethee SG, Welsh P, Papacosta O, et al. Elevated parathyroid hormone, but not vitamin D deficiency, is associated with increased risk of heart failure in older men with and without cardiovascular disease. Circ Heart Fail. 2014;7:732\u20139.","journal-title":"Circ Heart Fail"},{"key":"357_CR42","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1097\/SMJ.0b013e31823c4155","volume":"105","author":"AN Peiris","year":"2012","unstructured":"Peiris AN, Youssef D, Grant WB. Secondary hyperparathyroidism: benign bystander or culpable contributor to adverse health outcomes? South Med J. 2012;105:36\u201342.","journal-title":"South Med J"},{"key":"357_CR43","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.jsbmb.2006.12.081","volume":"103","author":"A Rahman","year":"2007","unstructured":"Rahman A, Hershey S, Ahmed S, et al. Heart extracellular matrix gene expression profile in the vitamin D receptor knockout mice. J Steroid Biochem Mol Biol. 2007;103:416\u20139.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"357_CR44","doi-asserted-by":"publisher","first-page":"e0128655","DOI":"10.1371\/journal.pone.0128655","volume":"10","author":"A Meredith","year":"2015","unstructured":"Meredith A, Boroomand S, Carthy J, et al. 1,25 Dihydroxyvitamin D3 inhibits TGF\u03b21-mediated primary human cardiac myofibroblast activation. PLoS One. 2015;10:e0128655.","journal-title":"PLoS One"},{"key":"357_CR45","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/j.hlc.2018.01.006","volume":"27","author":"T Le","year":"2018","unstructured":"Le T, Ogawa M, Kizana E, et al. Vitamin D improves cardiac function after myocardial infarction through modulation of resident cardiac progenitor cells. Heart Lung Circ. 2018;27:967\u201375.","journal-title":"Heart Lung Circ"},{"key":"357_CR46","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1172\/JCI31044","volume":"117","author":"BC Berk","year":"2007","unstructured":"Berk BC, Fujiwara K, Lehoux S. ECM remodeling in hypertensive heart disease. J Clin Investig. 2007;117:568\u201375.","journal-title":"J Clin Investig"},{"key":"357_CR47","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1093\/cvr\/cvn261","volume":"81","author":"KT Weber","year":"2009","unstructured":"Weber KT, Weglicki WB, Simpson RU. Macro- and micronutrient dyshomeostasis in the adverse structural remodelling of myocardium. Cardiovasc Res. 2009;81:500.","journal-title":"Cardiovasc Res"},{"key":"357_CR48","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s00392-011-0394-0","volume":"101","author":"H Khalili","year":"2012","unstructured":"Khalili H, Talasaz AH, Salarifar M. Serum vitamin D concentration status and its correlation with early biomarkers of remodeling following acute myocardial infarction. Clin Res Cardiol. 2012;101:321\u20137.","journal-title":"Clin Res Cardiol"},{"key":"357_CR49","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1093\/qjmed\/95.12.787","volume":"95","author":"PM Timms","year":"2002","unstructured":"Timms PM, Mannan N, Hitman GA, et al. Circulating MMP9, vitamin D and variation in the TIMP-1 response with VDR genotype: mechanisms for inflammatory damage in chronic disorders? QJM Mon J Assoc Physicians. 2002;95:787\u201396.","journal-title":"QJM Mon J Assoc Physicians"},{"key":"357_CR50","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1111\/j.1365-2249.2005.02961.x","volume":"143","author":"O Equils","year":"2006","unstructured":"Equils O, Naiki Y, Shapiro AM, et al. 1,25-Dihydroxyvitamin D inhibits lipopolysaccharide-induced immune activation in human endothelial cells. Clin Exp Immunol. 2006;143:58\u201364.","journal-title":"Clin Exp Immunol"},{"key":"357_CR51","first-page":"1714896","volume":"2018","author":"M Zhang","year":"2018","unstructured":"Zhang M, Lin L, Xu C, et al. VDR agonist prevents diabetic endothelial dysfunction through inhibition of prolyl isomerase-1-mediated mitochondrial oxidative stress and inflammation. Oxid Med Cell Longev. 2018;2018:1714896.","journal-title":"Oxid Med Cell Longev"},{"key":"357_CR52","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.jsbmb.2009.11.002","volume":"118","author":"S Chen","year":"2010","unstructured":"Chen S, Law CS, Gardner DG. Vitamin D-dependent suppression of endothelin-induced vascular smooth muscle cell proliferation through inhibition of CDK2 activity. J Steroid Biochem Mol Biol. 2010;118:135\u201341.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"357_CR53","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1097\/HCO.0000000000000108","volume":"29","author":"AR Menezes","year":"2014","unstructured":"Menezes AR, Lamb MC, Lavie CJ, DiNicolantonio JJ. Vitamin D and atherosclerosis. Curr Opin Cardiol. 2014;29:571\u20137.","journal-title":"Curr Opin Cardiol"},{"key":"357_CR54","doi-asserted-by":"publisher","first-page":"2517","DOI":"10.1161\/CIRCULATIONAHA.113.002654","volume":"128","author":"E Kassi","year":"2013","unstructured":"Kassi E, Adamopoulos C, Basdra EK, Papavassiliou AG. Role of vitamin D in atherosclerosis. Circulation. 2013;128:2517\u201331.","journal-title":"Circulation"},{"key":"357_CR55","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1093\/eurjhf\/hfs091","volume":"14","author":"T Fall","year":"2012","unstructured":"Fall T, Shiue I, Bergea af Geijerstam P, et al. Relations of circulating vitamin D concentrations with left ventricular geometry and function. Eur J Heart Fail. 2012;14:985\u201391.","journal-title":"Eur J Heart Fail"},{"key":"357_CR56","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1111\/j.1532-5415.2007.01601.x","volume":"56","author":"RS Boxer","year":"2008","unstructured":"Boxer RS, Dauser DA, Walsh SJ, et al. The association between vitamin D and inflammation with the 6-minute walk and frailty in patients with heart failure. J Am Geriatr Soc. 2008;56:454\u201361.","journal-title":"J Am Geriatr Soc"},{"key":"357_CR57","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/j.ahj.2010.08.004","volume":"160","author":"RS Boxer","year":"2010","unstructured":"Boxer RS, Kenny AM, Cheruvu VK, et al. Serum 25-hydroxyvitamin D concentration is associated with functional capacity in older adults with heart failure. Am Heart J. 2010;160:893\u20139.","journal-title":"Am Heart J"},{"key":"357_CR58","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1007\/s12020-017-1282-9","volume":"58","author":"F Saponaro","year":"2017","unstructured":"Saponaro F, Marcocci C, Zucchi R, et al. Hypovitaminosis D in patients with heart failure: effects on functional capacity and patients\u2019 survival. Endocrine. 2017;58:574\u201381.","journal-title":"Endocrine"},{"key":"357_CR59","doi-asserted-by":"publisher","first-page":"3927","DOI":"10.1210\/jc.2008-0784","volume":"93","author":"S Pilz","year":"2008","unstructured":"Pilz S, Marz W, Wellnitz B, et al. Association of vitamin D deficiency with heart failure and sudden cardiac death in a large cross-sectional study of patients referred for coronary angiography. J Clin Endocrinol Metab. 2008;93:3927\u201335.","journal-title":"J Clin Endocrinol Metab"},{"key":"357_CR60","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1177\/1074248413517747","volume":"19","author":"MP Dorsch","year":"2014","unstructured":"Dorsch MP, Nemerovski CW, Ellingrod VL, et al. Vitamin D receptor genetics on extracellular matrix biomarkers and hemodynamics in systolic heart failure. J Cardiovasc Pharmacol Ther. 2014;19:439\u201345.","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"357_CR61","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.cardfail.2018.09.006","volume":"24","author":"K Otani","year":"2018","unstructured":"Otani K, Higa Y, Tanaka K, et al. Relations of vitamin D status with B-type natriuretic peptide levels and the risk of cardiac events in Japanese subjects with heart failure. J Cardiac Fail. 2018;24:803\u20135.","journal-title":"J Cardiac Fail"},{"key":"357_CR62","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1111\/anec.12105","volume":"19","author":"WR Chen","year":"2014","unstructured":"Chen WR, Liu ZY, Shi Y, et al. Relation of low vitamin D to nonvalvular persistent atrial fibrillation in Chinese patients. Ann Noninvasive Electrocardiol. 2014;19:166\u201373.","journal-title":"Ann Noninvasive Electrocardiol"},{"key":"357_CR63","doi-asserted-by":"publisher","first-page":"140","DOI":"10.15171\/jcvtr.2016.29","volume":"8","author":"S Gode","year":"2016","unstructured":"Gode S, Aksu T, Demirel A, et al. Effect of vitamin D deficiency on the development of postoperative atrial fibrillation in coronary artery bypass patients. J Cardiovasc Thorac Res. 2016;8:140\u20136.","journal-title":"J Cardiovasc Thorac Res"},{"key":"357_CR64","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1111\/jce.12309","volume":"25","author":"DA Hanafy","year":"2014","unstructured":"Hanafy DA, Chang SL, Lu YY, et al. Electromechanical effects of 1,25-dihydroxyvitamin D with antiatrial fibrillation activities. J Cardiovasc Electrophysiol. 2014;25:317\u201323.","journal-title":"J Cardiovasc Electrophysiol"},{"key":"357_CR65","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s00059-017-4630-x","volume":"44","author":"A Separham","year":"2019","unstructured":"Separham A, Pourafkari L, Kazemi B, et al. Vitamin D deficiency and functional response to CRT in heart failure patients. Herz. 2019;44:147\u201354.","journal-title":"Herz."},{"key":"357_CR66","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1002\/ncp.10078","volume":"33","author":"FA Obeid","year":"2018","unstructured":"Obeid FA, Yost G. Effect of vitamin D level on clinical outcomes in patients undergoing left ventricular assist device implantation. Nutr Clin Pract. 2018;33:825\u201330.","journal-title":"Nutr Clin Pract."},{"key":"357_CR67","doi-asserted-by":"publisher","DOI":"10.1007\/s00394-018-1806-y","author":"RM Cubbon","year":"2018","unstructured":"Cubbon RM, Lowry JE, Drozd M, et al. Vitamin D deficiency is an independent predictor of mortality in patients with chronic heart failure. Eur J Nutr. 2018. \nhttps:\/\/doi.org\/10.1007\/s00394-018-1806-y\n\n.","journal-title":"Eur J Nutr."},{"key":"357_CR68","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1530\/EC-18-0207","volume":"7","author":"F Saponaro","year":"2018","unstructured":"Saponaro F, Saba A, Frascarelli S, et al. Vitamin D measurement and effect on outcome in a cohort of patients with heart failure. Endocr Connect. 2018;7:957\u201364.","journal-title":"Endocr Connect"},{"key":"357_CR69","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.ejheart.2008.01.013","volume":"10","author":"A Zittermann","year":"2008","unstructured":"Zittermann A, Schleithoff SS, Gotting C, et al. Poor outcome in end-stage heart failure patients with low circulating calcitriol levels. Eur J Heart Fail. 2008;10:321\u20137.","journal-title":"Eur J Heart Fail"},{"key":"357_CR70","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.jchf.2014.11.013","volume":"3","author":"PL Lutsey","year":"2015","unstructured":"Lutsey PL, Michos ED, Misialek JR, et al. Race and vitamin D binding protein gene polymorphisms modify the association of 25-hydroxyvitamin D and incident heart failure: the ARIC (Atherosclerosis Risk in Communities) Study. JACC Heart Fail. 2015;3:347\u201356.","journal-title":"JACC Heart Fail"},{"key":"357_CR71","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1186\/s12872-017-0707-y","volume":"17","author":"HD Moretti","year":"2017","unstructured":"Moretti HD, Colucci VJ, Berry BD. Vitamin D3 repletion versus placebo as adjunctive treatment of heart failure patient quality of life and hormonal indices: a randomized, double-blind, placebo-controlled trial. BMC Cardiovasc Disord. 2017;17:274.","journal-title":"BMC Cardiovasc Disord"},{"key":"357_CR72","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.numecd.2014.02.015","volume":"24","author":"A Dalbeni","year":"2014","unstructured":"Dalbeni A, Scaturro G, Degan M, et al. Effects of six months of vitamin D supplementation in patients with heart failure: a randomized double-blind controlled trial. Nutr Metab Cardiovasc Dis NMCD. 2014;24:861\u20138.","journal-title":"Nutr Metab Cardiovasc Dis NMCD"},{"key":"357_CR73","doi-asserted-by":"publisher","first-page":"2593","DOI":"10.1016\/j.jacc.2016.03.508","volume":"67","author":"KK Witte","year":"2016","unstructured":"Witte KK, Byrom R, Gierula J, et al. Effects of vitamin D on cardiac function in patients with chronic HF: the VINDICATE Study. J Am Coll Cardiol. 2016;67:2593\u2013603.","journal-title":"J Am Coll Cardiol"},{"key":"357_CR74","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.ijcard.2019.01.027","volume":"280","author":"A Zittermann","year":"2019","unstructured":"Zittermann A, Ernst JB, Prokop S, et al. Vitamin D supplementation of 4000\u00a0IU daily and cardiac function in patients with advanced heart failure: the EVITA trial. Int J Cardiol. 2019;280:117\u201323.","journal-title":"Int J Cardiol"},{"key":"357_CR75","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.cardfail.2014.01.019","volume":"20","author":"RS Boxer","year":"2014","unstructured":"Boxer RS, Hoit BD, Schmotzer BJ, et al. The effect of vitamin d on aldosterone and health status in patients with heart failure. J Cardiac Fail. 2014;20:334\u201342.","journal-title":"J Cardiac Fail"},{"key":"357_CR76","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.jchf.2012.11.003","volume":"1","author":"RS Boxer","year":"2013","unstructured":"Boxer RS, Kenny AM, Schmotzer BJ, et al. A randomized controlled trial of high dose vitamin D3 in patients with heart failure. JACC Heart Fail. 2013;1:84\u201390.","journal-title":"JACC Heart Fail"},{"key":"357_CR77","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1093\/eurheartj\/ehx235","volume":"38","author":"A Zittermann","year":"2017","unstructured":"Zittermann A, Ernst JB, Prokop S, et al. Effect of vitamin D on all-cause mortality in heart failure (EVITA): a 3-year randomized clinical trial with 4000\u00a0IU vitamin D daily. Eur Heart J. 2017;38:2279\u201386.","journal-title":"Eur Heart J"},{"key":"357_CR78","doi-asserted-by":"publisher","first-page":"5015417","DOI":"10.1155\/2018\/5015417","volume":"2018","author":"A Zittermann","year":"2018","unstructured":"Zittermann A, Ernst JB, Prokop S, et al. Effects of vitamin D supplementation on renin and aldosterone concentrations in patients with advanced heart failure: the EVITA trial. Int J Endocrinol. 2018;2018:5015417.","journal-title":"Int J Endocrinol"},{"key":"357_CR79","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1002\/clc.22473","volume":"39","author":"WL Jiang","year":"2016","unstructured":"Jiang WL, Gu HB, Zhang YF, et al. Vitamin D supplementation in the treatment of chronic heart failure: a meta-analysis of randomized controlled trials. Clin Cardiol. 2016;39:56\u201361.","journal-title":"Clin Cardiol"},{"key":"357_CR80","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/j.numecd.2017.07.009","volume":"27","author":"C D\u2019Amore","year":"2017","unstructured":"D\u2019Amore C, Marsico F, Parente A, et al. Vitamin D deficiency and clinical outcome in patients with chronic heart failure: a review. Nutr Metab Cardiovasc Dis NMCD. 2017;27:837\u201349.","journal-title":"Nutr Metab Cardiovasc Dis NMCD"},{"key":"357_CR81","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/S2213-8587(17)30357-1","volume":"5","author":"P Autier","year":"2017","unstructured":"Autier P, Mullie P, Macacu A, et al. Effect of vitamin D supplementation on non-skeletal disorders: a systematic review of meta-analyses and randomised trials. Lancet Diabetes Endocrinol. 2017;5:986\u20131004.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"357_CR82","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1093\/eurheartj\/ehx341","volume":"38","author":"RA de Boer","year":"2017","unstructured":"de Boer RA, Meems LMG, van Veldhuisen DJ. Vitamin D supplementation in heart failure: case closed? Eur Heart J. 2017;38:2287\u20139.","journal-title":"Eur Heart J"},{"key":"357_CR83","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.jacc.2017.05.031","volume":"70","author":"I Al Mheid","year":"2017","unstructured":"Al Mheid I, Quyyumi AA. Vitamin D and cardiovascular disease: controversy unresolved. J Am Coll Cardiol. 2017;70:89\u2013100.","journal-title":"J Am Coll Cardiol"},{"key":"357_CR84","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1161\/CIRCGENETICS.116.001396","volume":"9","author":"D Manousaki","year":"2016","unstructured":"Manousaki D, Mokry LE, Ross S, et al. Mendelian randomization studies do not support a role for vitamin D in coronary artery disease. Circ Cardiovasc Genet. 2016;9:349\u201356.","journal-title":"Circ Cardiovasc Genet"},{"key":"357_CR85","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1093\/ije\/dyv078","volume":"44","author":"P Brondum-Jacobsen","year":"2015","unstructured":"Brondum-Jacobsen P, Benn M, Afzal S, Nordestgaard BG. No evidence that genetically reduced 25-hydroxyvitamin D is associated with increased risk of ischaemic heart disease or myocardial infarction: a Mendelian randomization study. Int J Epidemiol. 2015;44:651\u201361.","journal-title":"Int J Epidemiol"},{"key":"357_CR86","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.numecd.2016.04.011","volume":"26","author":"M Golzarand","year":"2016","unstructured":"Golzarand M, Shab-Bidar S, Koochakpoor G, et al. Effect of vitamin D3 supplementation on blood pressure in adults: an updated meta-analysis. Nutr Metab Cardiovasc Dis NMCD. 2016;26:663\u201373.","journal-title":"Nutr Metab Cardiovasc Dis NMCD"},{"key":"357_CR87","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1001\/jama.2014.13204","volume":"312","author":"K Amrein","year":"2014","unstructured":"Amrein K, Schnedl C, Holl A, et al. Effect of high-dose vitamin D3 on hospital length of stay in critically ill patients with vitamin D deficiency: the VITdAL-ICU randomized clinical trial. JAMA. 2014;312:1520\u201330.","journal-title":"JAMA"},{"key":"357_CR88","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.maturitas.2018.05.010","volume":"115","author":"M Apostolakis","year":"2018","unstructured":"Apostolakis M, Armeni E, Bakas P, Lambrinoudaki I. Vitamin D and cardiovascular disease. Maturitas. 2018;115:1\u201322.","journal-title":"Maturitas"}],"container-title":["American Journal of Cardiovascular Drugs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40256-019-00357-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40256-019-00357-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40256-019-00357-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,8]],"date-time":"2020-07-08T23:22:14Z","timestamp":1594250534000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40256-019-00357-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,10]]},"references-count":88,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["357"],"URL":"https:\/\/doi.org\/10.1007\/s40256-019-00357-1","relation":{},"ISSN":["1175-3277","1179-187X"],"issn-type":[{"value":"1175-3277","type":"print"},{"value":"1179-187X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,10]]},"assertion":[{"value":"10 July 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"This study was supported by Grants from the National Natural Science Foundation of China (Grant no. 81800278) and the Natural Science Foundation of Fujian Province (Grant no. 13171570) to Dr. Liming Lin and the Natural Science Foundation of Fujian Province (Grant no. 13181097) to Dr. Meifang Wu.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Meifang Wu, Kaizu Xu, Ying Wu, and Liming Lin declare that they have no potential conflicts of interest that might be relevant to the contents of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}